A total of 10% to 15% of breast tumors do not express estrogen receptor (ER) or progesterone receptor (PR), and are HER2 amplification negative (triple-negative breast cancer—TNBC; ref. 1). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.